Current Edition

Regional News

Novartis, busy with its restructuring, sells 5 eye drugs for up to $175M

Amid a major restructuring and the spinoff of generics unit Sandoz, Novartis isn’t done shaking things up. The pharma giant has sold five of its …

Continue Reading →
Regional News

Court swats down Vanda’s patent suit against Teva and Apotex, clearing the way for Hetlioz generics

The clock is ticking on Vanda Pharmaceuticals’ sleep disorder drug Hetlioz—and, Tuesday, it got louder. A federal court in Delaware has not only rejected Vanda’s claim …

Continue Reading →
Regional News

J&J bows out of Horizon bid as Amgen and Sanofi eye cash plays for rare disease drugmaker

The battle to absorb rare disease drugmaker Horizon Therapeutics will be waged with cash. That was the message from interested bidders Sanofi and Amgen, at …

Continue Reading →
Regional News

Pfizer, BioNTech strike back at Moderna with mRNA vaccine patent lawsuit

As the salad days of pandemic vaccine sales wane, two mRNA camps are taking a legal stand on the global stage—and duking it out in …

Continue Reading →
Regional News

AbbVie’s Rinvoq retakes the crown from Sanofi’s Dupixent as the top TV drug ad spender in November

Thanks to a huge end-of-year splurge, AbbVie’s immunology drug Rinvoq has retaken the top spot as having the biggest TV drug ad spend in November, …

Continue Reading →
Regional News

Emergent snags speedy FDA review, potentially teeing up over-the-counter Narcan by next spring

Last month, the FDA showed it may be ready to play ball on approving nonprescription naloxone. Now, one of the overdose reversal drug’s flagship brands—Emergent …

Continue Reading →
Regional News

SABCS: Lilly aims Verzenio at broader post-surgery breast cancer nod as Novartis’ rival draws near. Will FDA bite?

When Eli Lilly’s Verzenio snagged an FDA go-ahead to treat certain breast cancer patients after surgery, the first-in-class nod was weakened by an unexpected limitation. …

Continue Reading →
Regional News

Kyowa Kirin offloads mature drugs to Grünenthal amid ‘challenging business environment’

Following a biopharma industry trend, Kyowa Kirin is narrowing its focus by offloading some mature medicines. The Japanese drugmaker will spin its international established medicines …

Continue Reading →
Regional News

Bayer’s blockbuster hopeful Nubeqa debuts in later-stage prostate cancer in UK under early access program

Thanks to a new early access deal and the intercontinental oncology effort Project Orbis, England will be the first European country where patients with later-stage …

Continue Reading →
Regional News

Spying new horizons, Xeris starts work on subcutaneous version of rare disease drug

Horizon Therapeutics has teamed up with Xeris Biopharma to create an ultra-concentrated, ready-to-use, subcutaneous formulation of teprotumumab, handing over an upfront payment and offering milestones …

Continue Reading →